日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies

ACTIV-2 研究中,Tixagevimab/cilgavimab 或安慰剂治疗 COVID-19 的安全性、药代动力学以及中和抗体和抗药抗体

Bender Ignacio, Rachel A; Chew, Kara W; Moser, Carlee; Currier, Judith S; Eron, Joseph J; Javan, Arzhang Cyrus; Giganti, Mark J; Ritz, Justin; Gibbs, Michael; Kouekam, Hervé Tchouakam; Esser, Mark T; Daar, Eric S; Choudhary, Manish; Deo, Rinki; Fletcher, Courtney V; Li, Jonathan Z; Hughes, Michael D; Smith, Davey; Wohl, David Alain

Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy

通过肌内或静脉注射抗病毒单克隆抗体疗法快速清除可培养的SARS-CoV-2病毒

Deo, Rinki; Choudhary, Manish C; Glover, Owen T; Ignacio, Rachel Bender; Boucau, Julie; Chew, Kara W; Moser, Carlee; Currier, Judith S; Eron, Joseph J; Javan, Arzhang Cyrus; Giganti, Mark J; Aga, Evgenia; Gibbs, Michael; Cohen, Taylor; Streicher, Katie; Soboleva, Karina; Fletcher, Courtney V; Daar, Eric S; Greninger, Alexander L; Coombs, Robert W; Fischer, William; Hughes, Michael D; Smith, Davey; Wohl, David Alain; Barczak, Amy K; Li, Jonathan Z

A community-based task shifting program in 25 remote indigenous communities in Nunavut, Canada

加拿大努纳武特地区25个偏远原住民社区开展的社区任务转移计划

Toffner, Greg; Koff, David Alain; Drossos, Alexander; Tsegmed, Uranchimeg; Baumann, Margaret Andrea

Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial

在突发传染病大流行背景下实施无缝衔接的二/三期研究设计:从 ACTIV-2 平台 COVID-19 治疗试验中汲取的经验教训

Giganti, Mark J; Chew, Kara W; Moser, Carlee; Eron, Joseph J; Pinilla, Mauricio; Li, Jonathan Z; Ritz, Justin; Javan, Arzhang Cyrus; Wohl, David Alain; Daar, Eric S; Currier, Judith S; Smith, Davey M; Hughes, Michael D

Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial

SAB-185治疗非住院COVID-19成年患者的安全性和有效性:一项随机临床试验

Chew, Kara W; Taiwo, Babafemi O; Moser, Carlee; Daar, Eric S; Wohl, David Alain; Ritz, Justin; Javan, Arzhang Cyrus; Li, Jonathan Z; Fischer, William; Greninger, Alexander L; Bausch, Christoph; Luke, Thomas; Call, Robert; Neytman, Gene; Giganti, Mark J; Fletcher, Courtney V; Hughes, Michael D; Eron, Joseph J; Currier, Judith S; Smith, Davey M

Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2

在针对严重急性呼吸综合征冠状病毒2的单克隆抗体治疗中,单活性与双活性单克隆抗体治疗耐药性和病毒动力学的特征分析

Choudhary, Manish C; Deo, Rinki; Evering, Teresa H; Chew, Kara W; Giganti, Mark J; Moser, Carlee; Ritz, Justin; Regan, James; Flynn, James P; Crain, Charles R; Wohl, David Alain; Currier, Judith S; Eron, Joseph J; Margolis, David; Zhu, Qing; Zhon, Lijie; Ya, Li; Greninger, Alexander L; Hughes, Michael D; Smith, Davey; Daar, Eric S; Li, Jonathan Z

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

联合使用SARS-CoV-2中和单克隆抗体Amubarvimab和Romlusevimab治疗非住院COVID-19患者的安全性和有效性

Evering, Teresa H; Chew, Kara W; Giganti, Mark J; Moser, Carlee; Pinilla, Mauricio; Wohl, David Alain; Currier, Judith S; Eron, Joseph J; Javan, Arzhang Cyrus; Bender Ignacio, Rachel; Margolis, David; Zhu, Qing; Ma, Ji; Zhong, Lijie; Yan, Li; D'Andrea Nores, Ulises; Hoover, Keila; Mocherla, Bharat; Choudhary, Manish C; Deo, Rinki; Ritz, Justin; Fischer, William A; Fletcher, Courtney V; Li, Jonathan Z; Hughes, Michael D; Smith, Davey; Daar, Eric S

Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials

在非住院 COVID-19 患者中,肌注或静脉注射联合使用 Tixagevimab 和 Cilgavimab 的安全性和有效性:2 项随机临床试验

Bender Ignacio, Rachel A; Chew, Kara W; Moser, Carlee; Currier, Judith S; Eron, Joseph J; Javan, Arzhang Cyrus; Giganti, Mark J; Aga, Evgenia; Gibbs, Michael; Tchouakam Kouekam, Hervé; Johnsson, Eva; Esser, Mark T; Hoover, Keila; Neytman, Gene; Newell, Matthew; Daar, Eric S; Fischer, William; Fletcher, Courtney V; Li, Jonathan Z; Greninger, Alexander L; Coombs, Robert W; Hughes, Michael D; Smith, Davey; Wohl, David Alain

Post-Ebola Symptoms 7 Years After Infection: The Natural History of Long Ebola

埃博拉病毒感染7年后出现的后遗症:长期埃博拉病毒感染的自然史

Wohl, David Alain; Fischer, William A; Mei, Wenwen; Zou, Fei; Tozay, Samuel; Reeves, Edwin; Pewu, Korto; Demarco, Jean; Schieffelin, John; Johnson, Henrietta; Conneh, Tonia; Williams, Gerald; McMillian, Darrius; Brown, Jerry

Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19

SAB-185(一种新型多克隆抗体疗法)治疗非住院成人新冠肺炎患者的二期安全性和抗病毒活性研究

Taiwo, Babafemi O; Chew, Kara W; Moser, Carlee; Wohl, David Alain; Daar, Eric S; Li, Jonathan Z; Greninger, Alexander L; Bausch, Christoph; Luke, Thomas; Hoover, Keila; Neytman, Gene; Giganti, Mark J; Olefsky, Maxine; Javan, Arzhang Cyrus; Fletcher, Courtney V; Eron, Joseph J; Currier, Judith S; Hughes, Michael D; Smith, Davey M